Canada?s packaging firm GELPAC acquires US manufacturer WBC
A pharmaceutical client was at risk of a product recall due to a capping problem with a new tablet formulation. This document explains how DJA Pharma prevented a costly recall with a simple, elegant and effective solution.
Enter your details here to receive your free whitepaper.Close survey
Canada-based high-performance packaging solutions provider GELPAC has acquired US single-use blown polymer film manufacturer WBC Extrusion Products.
Financial details of the transaction remain undisclosed.
WBC?s manufacturing facility in Haverhill, Massachusetts, will join GELPAC’s existing poly plants in Farnham, Quebec and Brampton, Ontario.
GELPAC CEO Alain Robillard said: “With this acquisition, we will strengthen our competitive position in North America.
?By combining the strengths of the three plants and by integrating our respective R&D initiatives, ongoing innovations to the manufacturing process and procurement strategies, we will offer the best performing poly solutions in the market.”
Institutional investors such as CDPQ, le Fonds Manufacturier Qu?b?cois and Namakor have financially and strategically supported the agreement.
Robillard added: ?We are pleased that they recognised the depth of GELPAC’s commitment to the future of the company. The addition of this complementary production capacity to our comprehensive products portfolio will allow us to provide our North American clients with even greater value.
?We look forward to working with the new members of our team to reach ever-higher levels of excellence.”
GELPAC provides packaging solutions to the North American food, chemical and construction industries.
The company?s product portfolio includes paper bags, multiwall paper bags and polyethene packaging.
WBC specialises in producing monolayer high-density polyethene and polypropylene films for its customers in the north-eastern region of the US. Free WhitepaperSix essential ways to improve your pharmaceutical quality system
Enter your details here to receive your free whitepaper.Close survey Close
» Publication Date: 07/11/2019
This project has received funding from the Bio-Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 745828